nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—SLCO1B3—Mycophenolate mofetil—psoriasis	0.133	0.176	CbGbCtD
Gadoxetate—ABCC3—Cyclosporine—psoriasis	0.114	0.151	CbGbCtD
Gadoxetate—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0775	0.103	CbGbCtD
Gadoxetate—ABCC2—Mycophenolate mofetil—psoriasis	0.0681	0.0903	CbGbCtD
Gadoxetate—ABCC3—Methotrexate—psoriasis	0.0601	0.0797	CbGbCtD
Gadoxetate—SLCO1B1—Cyclosporine—psoriasis	0.0587	0.0779	CbGbCtD
Gadoxetate—SLCO1B3—Methotrexate—psoriasis	0.0534	0.0708	CbGbCtD
Gadoxetate—ABCC2—Cyclosporine—psoriasis	0.0516	0.0684	CbGbCtD
Gadoxetate—ABCC4—Methotrexate—psoriasis	0.0459	0.0609	CbGbCtD
Gadoxetate—ABCC2—Dexamethasone—psoriasis	0.034	0.0451	CbGbCtD
Gadoxetate—SLCO1B1—Methotrexate—psoriasis	0.0311	0.0412	CbGbCtD
Gadoxetate—ABCC2—Methotrexate—psoriasis	0.0273	0.0362	CbGbCtD
Gadoxetate—Fatigue—Cyclosporine—psoriasis	0.000132	0.000535	CcSEcCtD
Gadoxetate—Hyperhidrosis—Hydrocortisone—psoriasis	0.000131	0.000533	CcSEcCtD
Gadoxetate—Constipation—Cyclosporine—psoriasis	0.000131	0.000531	CcSEcCtD
Gadoxetate—Dry mouth—Triamcinolone—psoriasis	0.00013	0.00053	CcSEcCtD
Gadoxetate—Renal failure—Methotrexate—psoriasis	0.00013	0.000529	CcSEcCtD
Gadoxetate—Decreased appetite—Mycophenolate mofetil—psoriasis	0.00013	0.000526	CcSEcCtD
Gadoxetate—Anorexia—Hydrocortisone—psoriasis	0.000129	0.000526	CcSEcCtD
Gadoxetate—Diarrhoea—Mycophenolic acid—psoriasis	0.000129	0.000525	CcSEcCtD
Gadoxetate—Angiopathy—Prednisone—psoriasis	0.000129	0.000524	CcSEcCtD
Gadoxetate—Conjunctivitis—Methotrexate—psoriasis	0.000129	0.000523	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000129	0.000523	CcSEcCtD
Gadoxetate—Immune system disorder—Prednisone—psoriasis	0.000128	0.000522	CcSEcCtD
Gadoxetate—Malaise—Dexamethasone—psoriasis	0.000128	0.000521	CcSEcCtD
Gadoxetate—Malaise—Betamethasone—psoriasis	0.000128	0.000521	CcSEcCtD
Gadoxetate—Anaphylactic shock—Triamcinolone—psoriasis	0.000128	0.000519	CcSEcCtD
Gadoxetate—Oedema—Triamcinolone—psoriasis	0.000128	0.000519	CcSEcCtD
Gadoxetate—Vertigo—Betamethasone—psoriasis	0.000128	0.000519	CcSEcCtD
Gadoxetate—Vertigo—Dexamethasone—psoriasis	0.000128	0.000519	CcSEcCtD
Gadoxetate—Syncope—Dexamethasone—psoriasis	0.000127	0.000518	CcSEcCtD
Gadoxetate—Syncope—Betamethasone—psoriasis	0.000127	0.000518	CcSEcCtD
Gadoxetate—Constipation—Mycophenolate mofetil—psoriasis	0.000127	0.000518	CcSEcCtD
Gadoxetate—Arrhythmia—Prednisone—psoriasis	0.000127	0.000516	CcSEcCtD
Gadoxetate—Infection—Triamcinolone—psoriasis	0.000127	0.000516	CcSEcCtD
Gadoxetate—Hypotension—Hydrocortisone—psoriasis	0.000127	0.000515	CcSEcCtD
Gadoxetate—Feeling abnormal—Cyclosporine—psoriasis	0.000126	0.000512	CcSEcCtD
Gadoxetate—Shock—Triamcinolone—psoriasis	0.000126	0.000511	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Cyclosporine—psoriasis	0.000125	0.000508	CcSEcCtD
Gadoxetate—Loss of consciousness—Dexamethasone—psoriasis	0.000125	0.000508	CcSEcCtD
Gadoxetate—Loss of consciousness—Betamethasone—psoriasis	0.000125	0.000508	CcSEcCtD
Gadoxetate—Dizziness—Mycophenolic acid—psoriasis	0.000125	0.000507	CcSEcCtD
Gadoxetate—Paraesthesia—Prednisolone—psoriasis	0.000125	0.000507	CcSEcCtD
Gadoxetate—Tachycardia—Triamcinolone—psoriasis	0.000125	0.000507	CcSEcCtD
Gadoxetate—Hyperhidrosis—Triamcinolone—psoriasis	0.000124	0.000502	CcSEcCtD
Gadoxetate—Convulsion—Betamethasone—psoriasis	0.000123	0.0005	CcSEcCtD
Gadoxetate—Convulsion—Dexamethasone—psoriasis	0.000123	0.0005	CcSEcCtD
Gadoxetate—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000123	0.000499	CcSEcCtD
Gadoxetate—Paraesthesia—Hydrocortisone—psoriasis	0.000122	0.000495	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000122	0.000495	CcSEcCtD
Gadoxetate—Urticaria—Cyclosporine—psoriasis	0.000121	0.000493	CcSEcCtD
Gadoxetate—Abdominal pain—Cyclosporine—psoriasis	0.000121	0.000491	CcSEcCtD
Gadoxetate—Body temperature increased—Cyclosporine—psoriasis	0.000121	0.000491	CcSEcCtD
Gadoxetate—Anxiety—Dexamethasone—psoriasis	0.000121	0.00049	CcSEcCtD
Gadoxetate—Anxiety—Betamethasone—psoriasis	0.000121	0.00049	CcSEcCtD
Gadoxetate—Vomiting—Mycophenolic acid—psoriasis	0.00012	0.000488	CcSEcCtD
Gadoxetate—Discomfort—Betamethasone—psoriasis	0.00012	0.000486	CcSEcCtD
Gadoxetate—Discomfort—Dexamethasone—psoriasis	0.00012	0.000486	CcSEcCtD
Gadoxetate—Rash—Mycophenolic acid—psoriasis	0.000119	0.000484	CcSEcCtD
Gadoxetate—Dermatitis—Mycophenolic acid—psoriasis	0.000119	0.000483	CcSEcCtD
Gadoxetate—Urticaria—Mycophenolate mofetil—psoriasis	0.000118	0.000481	CcSEcCtD
Gadoxetate—Headache—Mycophenolic acid—psoriasis	0.000118	0.000481	CcSEcCtD
Gadoxetate—Decreased appetite—Hydrocortisone—psoriasis	0.000118	0.00048	CcSEcCtD
Gadoxetate—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000118	0.000479	CcSEcCtD
Gadoxetate—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000118	0.000479	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000117	0.000476	CcSEcCtD
Gadoxetate—Fatigue—Hydrocortisone—psoriasis	0.000117	0.000476	CcSEcCtD
Gadoxetate—Vision blurred—Prednisone—psoriasis	0.000117	0.000474	CcSEcCtD
Gadoxetate—Anaphylactic shock—Betamethasone—psoriasis	0.000116	0.000471	CcSEcCtD
Gadoxetate—Anaphylactic shock—Dexamethasone—psoriasis	0.000116	0.000471	CcSEcCtD
Gadoxetate—Oedema—Betamethasone—psoriasis	0.000116	0.000471	CcSEcCtD
Gadoxetate—Oedema—Dexamethasone—psoriasis	0.000116	0.000471	CcSEcCtD
Gadoxetate—Infection—Dexamethasone—psoriasis	0.000115	0.000468	CcSEcCtD
Gadoxetate—Infection—Betamethasone—psoriasis	0.000115	0.000468	CcSEcCtD
Gadoxetate—Ill-defined disorder—Prednisone—psoriasis	0.000115	0.000467	CcSEcCtD
Gadoxetate—Paraesthesia—Triamcinolone—psoriasis	0.000115	0.000466	CcSEcCtD
Gadoxetate—Feeling abnormal—Prednisolone—psoriasis	0.000115	0.000465	CcSEcCtD
Gadoxetate—Shock—Betamethasone—psoriasis	0.000114	0.000464	CcSEcCtD
Gadoxetate—Shock—Dexamethasone—psoriasis	0.000114	0.000464	CcSEcCtD
Gadoxetate—Dyspnoea—Triamcinolone—psoriasis	0.000114	0.000463	CcSEcCtD
Gadoxetate—Nervous system disorder—Betamethasone—psoriasis	0.000114	0.000462	CcSEcCtD
Gadoxetate—Nervous system disorder—Dexamethasone—psoriasis	0.000114	0.000462	CcSEcCtD
Gadoxetate—Agitation—Prednisone—psoriasis	0.000114	0.000462	CcSEcCtD
Gadoxetate—Tachycardia—Dexamethasone—psoriasis	0.000113	0.00046	CcSEcCtD
Gadoxetate—Tachycardia—Betamethasone—psoriasis	0.000113	0.00046	CcSEcCtD
Gadoxetate—Hypersensitivity—Cyclosporine—psoriasis	0.000113	0.000457	CcSEcCtD
Gadoxetate—Nausea—Mycophenolic acid—psoriasis	0.000112	0.000456	CcSEcCtD
Gadoxetate—Hyperhidrosis—Dexamethasone—psoriasis	0.000112	0.000456	CcSEcCtD
Gadoxetate—Hyperhidrosis—Betamethasone—psoriasis	0.000112	0.000456	CcSEcCtD
Gadoxetate—Feeling abnormal—Hydrocortisone—psoriasis	0.000112	0.000455	CcSEcCtD
Gadoxetate—Malaise—Prednisone—psoriasis	0.000112	0.000454	CcSEcCtD
Gadoxetate—Vertigo—Prednisone—psoriasis	0.000111	0.000452	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000111	0.000451	CcSEcCtD
Gadoxetate—Syncope—Prednisone—psoriasis	0.000111	0.000451	CcSEcCtD
Gadoxetate—Anorexia—Dexamethasone—psoriasis	0.000111	0.000449	CcSEcCtD
Gadoxetate—Anorexia—Betamethasone—psoriasis	0.000111	0.000449	CcSEcCtD
Gadoxetate—Urticaria—Prednisolone—psoriasis	0.00011	0.000449	CcSEcCtD
Gadoxetate—Cardiac disorder—Methotrexate—psoriasis	0.00011	0.000448	CcSEcCtD
Gadoxetate—Fatigue—Triamcinolone—psoriasis	0.00011	0.000448	CcSEcCtD
Gadoxetate—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.00011	0.000446	CcSEcCtD
Gadoxetate—Asthenia—Cyclosporine—psoriasis	0.00011	0.000445	CcSEcCtD
Gadoxetate—Loss of consciousness—Prednisone—psoriasis	0.000109	0.000442	CcSEcCtD
Gadoxetate—Hypotension—Dexamethasone—psoriasis	0.000108	0.00044	CcSEcCtD
Gadoxetate—Hypotension—Betamethasone—psoriasis	0.000108	0.00044	CcSEcCtD
Gadoxetate—Pruritus—Cyclosporine—psoriasis	0.000108	0.000439	CcSEcCtD
Gadoxetate—Urticaria—Hydrocortisone—psoriasis	0.000108	0.000438	CcSEcCtD
Gadoxetate—Angiopathy—Methotrexate—psoriasis	0.000108	0.000438	CcSEcCtD
Gadoxetate—Immune system disorder—Methotrexate—psoriasis	0.000107	0.000436	CcSEcCtD
Gadoxetate—Abdominal pain—Hydrocortisone—psoriasis	0.000107	0.000436	CcSEcCtD
Gadoxetate—Body temperature increased—Hydrocortisone—psoriasis	0.000107	0.000436	CcSEcCtD
Gadoxetate—Convulsion—Prednisone—psoriasis	0.000107	0.000436	CcSEcCtD
Gadoxetate—Mediastinal disorder—Methotrexate—psoriasis	0.000107	0.000435	CcSEcCtD
Gadoxetate—Asthenia—Mycophenolate mofetil—psoriasis	0.000107	0.000434	CcSEcCtD
Gadoxetate—Chills—Methotrexate—psoriasis	0.000107	0.000433	CcSEcCtD
Gadoxetate—Pruritus—Mycophenolate mofetil—psoriasis	0.000105	0.000428	CcSEcCtD
Gadoxetate—Feeling abnormal—Triamcinolone—psoriasis	0.000105	0.000428	CcSEcCtD
Gadoxetate—Anxiety—Prednisone—psoriasis	0.000105	0.000427	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000105	0.000425	CcSEcCtD
Gadoxetate—Diarrhoea—Cyclosporine—psoriasis	0.000105	0.000425	CcSEcCtD
Gadoxetate—Paraesthesia—Dexamethasone—psoriasis	0.000104	0.000423	CcSEcCtD
Gadoxetate—Paraesthesia—Betamethasone—psoriasis	0.000104	0.000423	CcSEcCtD
Gadoxetate—Discomfort—Prednisone—psoriasis	0.000104	0.000423	CcSEcCtD
Gadoxetate—Hypersensitivity—Prednisolone—psoriasis	0.000102	0.000416	CcSEcCtD
Gadoxetate—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000102	0.000414	CcSEcCtD
Gadoxetate—Urticaria—Triamcinolone—psoriasis	0.000102	0.000413	CcSEcCtD
Gadoxetate—Dysgeusia—Methotrexate—psoriasis	0.000101	0.000412	CcSEcCtD
Gadoxetate—Body temperature increased—Triamcinolone—psoriasis	0.000101	0.000411	CcSEcCtD
Gadoxetate—Dizziness—Cyclosporine—psoriasis	0.000101	0.00041	CcSEcCtD
Gadoxetate—Oedema—Prednisone—psoriasis	0.000101	0.00041	CcSEcCtD
Gadoxetate—Anaphylactic shock—Prednisone—psoriasis	0.000101	0.00041	CcSEcCtD
Gadoxetate—Decreased appetite—Betamethasone—psoriasis	0.000101	0.00041	CcSEcCtD
Gadoxetate—Decreased appetite—Dexamethasone—psoriasis	0.000101	0.00041	CcSEcCtD
Gadoxetate—Infection—Prednisone—psoriasis	0.0001	0.000408	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Dexamethasone—psoriasis	0.0001	0.000407	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Betamethasone—psoriasis	0.0001	0.000407	CcSEcCtD
Gadoxetate—Back pain—Methotrexate—psoriasis	0.0001	0.000407	CcSEcCtD
Gadoxetate—Hypersensitivity—Hydrocortisone—psoriasis	0.0001	0.000406	CcSEcCtD
Gadoxetate—Fatigue—Dexamethasone—psoriasis	0.0001	0.000406	CcSEcCtD
Gadoxetate—Fatigue—Betamethasone—psoriasis	0.0001	0.000406	CcSEcCtD
Gadoxetate—Shock—Prednisone—psoriasis	9.94e-05	0.000404	CcSEcCtD
Gadoxetate—Nervous system disorder—Prednisone—psoriasis	9.91e-05	0.000403	CcSEcCtD
Gadoxetate—Tachycardia—Prednisone—psoriasis	9.86e-05	0.000401	CcSEcCtD
Gadoxetate—Dizziness—Mycophenolate mofetil—psoriasis	9.85e-05	0.0004	CcSEcCtD
Gadoxetate—Skin disorder—Prednisone—psoriasis	9.81e-05	0.000399	CcSEcCtD
Gadoxetate—Hyperhidrosis—Prednisone—psoriasis	9.76e-05	0.000397	CcSEcCtD
Gadoxetate—Vision blurred—Methotrexate—psoriasis	9.75e-05	0.000396	CcSEcCtD
Gadoxetate—Asthenia—Hydrocortisone—psoriasis	9.74e-05	0.000396	CcSEcCtD
Gadoxetate—Vomiting—Cyclosporine—psoriasis	9.71e-05	0.000395	CcSEcCtD
Gadoxetate—Rash—Cyclosporine—psoriasis	9.63e-05	0.000391	CcSEcCtD
Gadoxetate—Anorexia—Prednisone—psoriasis	9.63e-05	0.000391	CcSEcCtD
Gadoxetate—Dermatitis—Cyclosporine—psoriasis	9.62e-05	0.000391	CcSEcCtD
Gadoxetate—Pruritus—Hydrocortisone—psoriasis	9.6e-05	0.00039	CcSEcCtD
Gadoxetate—Ill-defined disorder—Methotrexate—psoriasis	9.6e-05	0.00039	CcSEcCtD
Gadoxetate—Headache—Cyclosporine—psoriasis	9.57e-05	0.000389	CcSEcCtD
Gadoxetate—Feeling abnormal—Dexamethasone—psoriasis	9.56e-05	0.000388	CcSEcCtD
Gadoxetate—Feeling abnormal—Betamethasone—psoriasis	9.56e-05	0.000388	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Dexamethasone—psoriasis	9.48e-05	0.000385	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Betamethasone—psoriasis	9.48e-05	0.000385	CcSEcCtD
Gadoxetate—Vomiting—Mycophenolate mofetil—psoriasis	9.47e-05	0.000385	CcSEcCtD
Gadoxetate—Hypersensitivity—Triamcinolone—psoriasis	9.42e-05	0.000383	CcSEcCtD
Gadoxetate—Rash—Mycophenolate mofetil—psoriasis	9.4e-05	0.000382	CcSEcCtD
Gadoxetate—Dermatitis—Mycophenolate mofetil—psoriasis	9.39e-05	0.000381	CcSEcCtD
Gadoxetate—Headache—Mycophenolate mofetil—psoriasis	9.33e-05	0.000379	CcSEcCtD
Gadoxetate—Malaise—Methotrexate—psoriasis	9.33e-05	0.000379	CcSEcCtD
Gadoxetate—Vertigo—Methotrexate—psoriasis	9.29e-05	0.000378	CcSEcCtD
Gadoxetate—Diarrhoea—Hydrocortisone—psoriasis	9.29e-05	0.000377	CcSEcCtD
Gadoxetate—Urticaria—Betamethasone—psoriasis	9.21e-05	0.000374	CcSEcCtD
Gadoxetate—Urticaria—Dexamethasone—psoriasis	9.21e-05	0.000374	CcSEcCtD
Gadoxetate—Dizziness—Prednisolone—psoriasis	9.19e-05	0.000374	CcSEcCtD
Gadoxetate—Asthenia—Triamcinolone—psoriasis	9.17e-05	0.000373	CcSEcCtD
Gadoxetate—Abdominal pain—Betamethasone—psoriasis	9.17e-05	0.000373	CcSEcCtD
Gadoxetate—Abdominal pain—Dexamethasone—psoriasis	9.17e-05	0.000373	CcSEcCtD
Gadoxetate—Body temperature increased—Betamethasone—psoriasis	9.17e-05	0.000373	CcSEcCtD
Gadoxetate—Body temperature increased—Dexamethasone—psoriasis	9.17e-05	0.000373	CcSEcCtD
Gadoxetate—Nausea—Cyclosporine—psoriasis	9.07e-05	0.000369	CcSEcCtD
Gadoxetate—Paraesthesia—Prednisone—psoriasis	9.07e-05	0.000369	CcSEcCtD
Gadoxetate—Pruritus—Triamcinolone—psoriasis	9.04e-05	0.000368	CcSEcCtD
Gadoxetate—Cough—Methotrexate—psoriasis	9.03e-05	0.000367	CcSEcCtD
Gadoxetate—Dizziness—Hydrocortisone—psoriasis	8.98e-05	0.000365	CcSEcCtD
Gadoxetate—Convulsion—Methotrexate—psoriasis	8.96e-05	0.000364	CcSEcCtD
Gadoxetate—Nausea—Mycophenolate mofetil—psoriasis	8.85e-05	0.00036	CcSEcCtD
Gadoxetate—Chest pain—Methotrexate—psoriasis	8.81e-05	0.000358	CcSEcCtD
Gadoxetate—Decreased appetite—Prednisone—psoriasis	8.78e-05	0.000357	CcSEcCtD
Gadoxetate—Rash—Prednisolone—psoriasis	8.76e-05	0.000356	CcSEcCtD
Gadoxetate—Dermatitis—Prednisolone—psoriasis	8.76e-05	0.000356	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	8.74e-05	0.000355	CcSEcCtD
Gadoxetate—Fatigue—Prednisone—psoriasis	8.71e-05	0.000354	CcSEcCtD
Gadoxetate—Headache—Prednisolone—psoriasis	8.71e-05	0.000354	CcSEcCtD
Gadoxetate—Discomfort—Methotrexate—psoriasis	8.7e-05	0.000354	CcSEcCtD
Gadoxetate—Constipation—Prednisone—psoriasis	8.64e-05	0.000351	CcSEcCtD
Gadoxetate—Vomiting—Hydrocortisone—psoriasis	8.63e-05	0.000351	CcSEcCtD
Gadoxetate—Rash—Hydrocortisone—psoriasis	8.56e-05	0.000348	CcSEcCtD
Gadoxetate—Dermatitis—Hydrocortisone—psoriasis	8.55e-05	0.000348	CcSEcCtD
Gadoxetate—Headache—Hydrocortisone—psoriasis	8.5e-05	0.000346	CcSEcCtD
Gadoxetate—Dizziness—Triamcinolone—psoriasis	8.45e-05	0.000343	CcSEcCtD
Gadoxetate—Anaphylactic shock—Methotrexate—psoriasis	8.44e-05	0.000343	CcSEcCtD
Gadoxetate—Infection—Methotrexate—psoriasis	8.39e-05	0.000341	CcSEcCtD
Gadoxetate—Feeling abnormal—Prednisone—psoriasis	8.32e-05	0.000338	CcSEcCtD
Gadoxetate—Asthenia—Dexamethasone—psoriasis	8.32e-05	0.000338	CcSEcCtD
Gadoxetate—Asthenia—Betamethasone—psoriasis	8.32e-05	0.000338	CcSEcCtD
Gadoxetate—Nervous system disorder—Methotrexate—psoriasis	8.28e-05	0.000336	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Prednisone—psoriasis	8.26e-05	0.000336	CcSEcCtD
Gadoxetate—Nausea—Prednisolone—psoriasis	8.26e-05	0.000336	CcSEcCtD
Gadoxetate—Pruritus—Betamethasone—psoriasis	8.21e-05	0.000333	CcSEcCtD
Gadoxetate—Pruritus—Dexamethasone—psoriasis	8.21e-05	0.000333	CcSEcCtD
Gadoxetate—Skin disorder—Methotrexate—psoriasis	8.2e-05	0.000333	CcSEcCtD
Gadoxetate—Hyperhidrosis—Methotrexate—psoriasis	8.16e-05	0.000332	CcSEcCtD
Gadoxetate—Vomiting—Triamcinolone—psoriasis	8.13e-05	0.00033	CcSEcCtD
Gadoxetate—Nausea—Hydrocortisone—psoriasis	8.06e-05	0.000328	CcSEcCtD
Gadoxetate—Rash—Triamcinolone—psoriasis	8.06e-05	0.000328	CcSEcCtD
Gadoxetate—Dermatitis—Triamcinolone—psoriasis	8.05e-05	0.000327	CcSEcCtD
Gadoxetate—Anorexia—Methotrexate—psoriasis	8.05e-05	0.000327	CcSEcCtD
Gadoxetate—Urticaria—Prednisone—psoriasis	8.02e-05	0.000326	CcSEcCtD
Gadoxetate—Headache—Triamcinolone—psoriasis	8.01e-05	0.000325	CcSEcCtD
Gadoxetate—Abdominal pain—Prednisone—psoriasis	7.98e-05	0.000324	CcSEcCtD
Gadoxetate—Body temperature increased—Prednisone—psoriasis	7.98e-05	0.000324	CcSEcCtD
Gadoxetate—Diarrhoea—Betamethasone—psoriasis	7.94e-05	0.000322	CcSEcCtD
Gadoxetate—Diarrhoea—Dexamethasone—psoriasis	7.94e-05	0.000322	CcSEcCtD
Gadoxetate—Hypotension—Methotrexate—psoriasis	7.89e-05	0.000321	CcSEcCtD
Gadoxetate—Dizziness—Dexamethasone—psoriasis	7.67e-05	0.000312	CcSEcCtD
Gadoxetate—Dizziness—Betamethasone—psoriasis	7.67e-05	0.000312	CcSEcCtD
Gadoxetate—Nausea—Triamcinolone—psoriasis	7.59e-05	0.000309	CcSEcCtD
Gadoxetate—Paraesthesia—Methotrexate—psoriasis	7.58e-05	0.000308	CcSEcCtD
Gadoxetate—Dyspnoea—Methotrexate—psoriasis	7.53e-05	0.000306	CcSEcCtD
Gadoxetate—Hypersensitivity—Prednisone—psoriasis	7.44e-05	0.000302	CcSEcCtD
Gadoxetate—Vomiting—Betamethasone—psoriasis	7.37e-05	0.0003	CcSEcCtD
Gadoxetate—Vomiting—Dexamethasone—psoriasis	7.37e-05	0.0003	CcSEcCtD
Gadoxetate—Decreased appetite—Methotrexate—psoriasis	7.34e-05	0.000298	CcSEcCtD
Gadoxetate—Rash—Dexamethasone—psoriasis	7.31e-05	0.000297	CcSEcCtD
Gadoxetate—Rash—Betamethasone—psoriasis	7.31e-05	0.000297	CcSEcCtD
Gadoxetate—Dermatitis—Betamethasone—psoriasis	7.31e-05	0.000297	CcSEcCtD
Gadoxetate—Dermatitis—Dexamethasone—psoriasis	7.31e-05	0.000297	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Methotrexate—psoriasis	7.29e-05	0.000296	CcSEcCtD
Gadoxetate—Fatigue—Methotrexate—psoriasis	7.28e-05	0.000296	CcSEcCtD
Gadoxetate—Headache—Dexamethasone—psoriasis	7.27e-05	0.000295	CcSEcCtD
Gadoxetate—Headache—Betamethasone—psoriasis	7.27e-05	0.000295	CcSEcCtD
Gadoxetate—Asthenia—Prednisone—psoriasis	7.25e-05	0.000294	CcSEcCtD
Gadoxetate—Pruritus—Prednisone—psoriasis	7.15e-05	0.00029	CcSEcCtD
Gadoxetate—Feeling abnormal—Methotrexate—psoriasis	6.96e-05	0.000283	CcSEcCtD
Gadoxetate—Diarrhoea—Prednisone—psoriasis	6.91e-05	0.000281	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Methotrexate—psoriasis	6.9e-05	0.000281	CcSEcCtD
Gadoxetate—Nausea—Dexamethasone—psoriasis	6.89e-05	0.00028	CcSEcCtD
Gadoxetate—Nausea—Betamethasone—psoriasis	6.89e-05	0.00028	CcSEcCtD
Gadoxetate—Urticaria—Methotrexate—psoriasis	6.71e-05	0.000273	CcSEcCtD
Gadoxetate—Dizziness—Prednisone—psoriasis	6.68e-05	0.000271	CcSEcCtD
Gadoxetate—Abdominal pain—Methotrexate—psoriasis	6.67e-05	0.000271	CcSEcCtD
Gadoxetate—Body temperature increased—Methotrexate—psoriasis	6.67e-05	0.000271	CcSEcCtD
Gadoxetate—Vomiting—Prednisone—psoriasis	6.42e-05	0.000261	CcSEcCtD
Gadoxetate—Rash—Prednisone—psoriasis	6.37e-05	0.000259	CcSEcCtD
Gadoxetate—Dermatitis—Prednisone—psoriasis	6.36e-05	0.000259	CcSEcCtD
Gadoxetate—Headache—Prednisone—psoriasis	6.33e-05	0.000257	CcSEcCtD
Gadoxetate—Hypersensitivity—Methotrexate—psoriasis	6.22e-05	0.000253	CcSEcCtD
Gadoxetate—Asthenia—Methotrexate—psoriasis	6.06e-05	0.000246	CcSEcCtD
Gadoxetate—Nausea—Prednisone—psoriasis	6e-05	0.000244	CcSEcCtD
Gadoxetate—Pruritus—Methotrexate—psoriasis	5.97e-05	0.000243	CcSEcCtD
Gadoxetate—Diarrhoea—Methotrexate—psoriasis	5.78e-05	0.000235	CcSEcCtD
Gadoxetate—Dizziness—Methotrexate—psoriasis	5.58e-05	0.000227	CcSEcCtD
Gadoxetate—Vomiting—Methotrexate—psoriasis	5.37e-05	0.000218	CcSEcCtD
Gadoxetate—Rash—Methotrexate—psoriasis	5.32e-05	0.000216	CcSEcCtD
Gadoxetate—Dermatitis—Methotrexate—psoriasis	5.32e-05	0.000216	CcSEcCtD
Gadoxetate—Headache—Methotrexate—psoriasis	5.29e-05	0.000215	CcSEcCtD
Gadoxetate—Nausea—Methotrexate—psoriasis	5.01e-05	0.000204	CcSEcCtD
